279 related articles for article (PubMed ID: 32197074)
1. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.
Mao D; Reuter CM; Ruzhnikov MRZ; Beck AE; Farrow EG; Emrick LT; Rosenfeld JA; Mackenzie KM; Robak L; Wheeler MT; Burrage LC; Jain M; Liu P; Calame D; Küry S; Sillesen M; Schmitz-Abe K; Tonduti D; Spaccini L; Iascone M; Genetti CA; Koenig MK; Graf M; Tran A; Alejandro M; ; Lee BH; Thiffault I; Agrawal PB; Bernstein JA; Bellen HJ; Chao HT
Am J Hum Genet; 2020 Apr; 106(4):570-583. PubMed ID: 32197074
[TBL] [Abstract][Full Text] [Related]
2. Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients.
Kantor L; Harding HP; Ron D; Schiffmann R; Kaneski CR; Kimball SR; Elroy-Stein O
Hum Genet; 2005 Oct; 118(1):99-106. PubMed ID: 16041584
[TBL] [Abstract][Full Text] [Related]
3. [CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
Labauge P; Fogli A; Niel F; Rodriguez D; Boespflug-Tanguy O
Rev Neurol (Paris); 2007 Sep; 163(8-9):793-9. PubMed ID: 17878805
[TBL] [Abstract][Full Text] [Related]
4. EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia.
Kuipers DJS; Mandemakers W; Lu CS; Olgiati S; Breedveld GJ; Fevga C; Tadic V; Carecchio M; Osterman B; Sagi-Dain L; Wu-Chou YH; Chen CC; Chang HC; Wu SL; Yeh TH; Weng YH; Elia AE; Panteghini C; Marotta N; Pauly MG; Kühn AA; Volkmann J; Lace B; Meijer IA; Kandaswamy K; Quadri M; Garavaglia B; Lohmann K; Bauer P; Mencacci NE; Lubbe SJ; Klein C; Bertoli-Avella AM; Bonifati V
Ann Neurol; 2021 Mar; 89(3):485-497. PubMed ID: 33236446
[TBL] [Abstract][Full Text] [Related]
5. Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.
Woody AL; Hsieh DT; McIver HK; Thomas LP; Rohena L
Am J Med Genet A; 2015 Apr; 167A(4):826-30. PubMed ID: 25758335
[TBL] [Abstract][Full Text] [Related]
6. The large spectrum of eIF2B-related diseases.
Fogli A; Boespflug-Tanguy O
Biochem Soc Trans; 2006 Feb; 34(Pt 1):22-9. PubMed ID: 16246171
[TBL] [Abstract][Full Text] [Related]
7.
Calame DG; Hainlen M; Takacs D; Ferrante L; Pence K; Emrick LT; Chao HT
Neurol Genet; 2021 Feb; 7(1):e539. PubMed ID: 33553620
[TBL] [Abstract][Full Text] [Related]
8. Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation. First Polish cases.
Mierzewska H; van der Knaap MS; Scheper GC; Jurkiewicz E; Schmidt-Sidor B; Szymańska K
Folia Neuropathol; 2006; 44(2):144-8. PubMed ID: 16823698
[TBL] [Abstract][Full Text] [Related]
9. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy.
Takano K; Tsuyusaki Y; Sato M; Takagi M; Anzai R; Okuda M; Iai M; Yamashita S; Okabe T; Aida N; Tsurusaki Y; Saitsu H; Matsumoto N; Osaka H
Brain Dev; 2015 Jun; 37(6):638-42. PubMed ID: 25457085
[TBL] [Abstract][Full Text] [Related]
10. Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease.
van Kollenburg B; van Dijk J; Garbern J; Thomas AA; Scheper GC; Powers JM; van der Knaap MS
J Neuropathol Exp Neurol; 2006 Jul; 65(7):707-15. PubMed ID: 16825957
[TBL] [Abstract][Full Text] [Related]
11. The effect of genotype on the natural history of eIF2B-related leukodystrophies.
Fogli A; Schiffmann R; Bertini E; Ughetto S; Combes P; Eymard-Pierre E; Kaneski CR; Pineda M; Troncoso M; Uziel G; Surtees R; Pugin D; Chaunu MP; Rodriguez D; Boespflug-Tanguy O
Neurology; 2004 May; 62(9):1509-17. PubMed ID: 15136673
[TBL] [Abstract][Full Text] [Related]
12. Case Report: A Novel
Wongkittichote P; Mar SS; McKinstry RC; Nguyen H
Front Genet; 2022; 13():893057. PubMed ID: 35783294
[TBL] [Abstract][Full Text] [Related]
13. [Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease].
Kashiwagi K; Ito T; Yokoyama S
Brain Nerve; 2017 Jan; 69(1):45-50. PubMed ID: 28126977
[TBL] [Abstract][Full Text] [Related]
14. A Recurrent
Macintosh J; Thiffault I; Pastinen T; Sztriha L; Bernard G
Child Neurol Open; 2023; 10():2329048X231176673. PubMed ID: 37284702
[No Abstract] [Full Text] [Related]
15. Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.
Horzinski L; Huyghe A; Cardoso MC; Gonthier C; Ouchchane L; Schiffmann R; Blanc P; Boespflug-Tanguy O; Fogli A
PLoS One; 2009 Dec; 4(12):e8318. PubMed ID: 20016818
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of mutations for the diagnosis of vanishing white matter disease.
Scali O; Di Perri C; Federico A
Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
[TBL] [Abstract][Full Text] [Related]
17. Possible
Waller SE; Morales-Briceño H; Williams L; Mohammad SS; Fellner A; Kumar KR; Tchan M; Fung VSC
Mov Disord Clin Pract; 2022 Feb; 9(2):240-244. PubMed ID: 35146062
[TBL] [Abstract][Full Text] [Related]
18. De Novo Variants in CNOT1, a Central Component of the CCR4-NOT Complex Involved in Gene Expression and RNA and Protein Stability, Cause Neurodevelopmental Delay.
Vissers LELM; Kalvakuri S; de Boer E; Geuer S; Oud M; van Outersterp I; Kwint M; Witmond M; Kersten S; Polla DL; Weijers D; Begtrup A; McWalter K; Ruiz A; Gabau E; Morton JEV; Griffith C; Weiss K; Gamble C; Bartley J; Vernon HJ; Brunet K; Ruivenkamp C; Kant SG; Kruszka P; Larson A; Afenjar A; Billette de Villemeur T; Nugent K; ; Raymond FL; Venselaar H; Demurger F; Soler-Alfonso C; Li D; Bhoj E; Hayes I; Hamilton NP; Ahmad A; Fisher R; van den Born M; Willems M; Sorlin A; Delanne J; Moutton S; Christophe P; Mau-Them FT; Vitobello A; Goel H; Massingham L; Phornphutkul C; Schwab J; Keren B; Charles P; Vreeburg M; De Simone L; Hoganson G; Iascone M; Milani D; Evenepoel L; Revencu N; Ward DI; Burns K; Krantz I; Raible SE; Murrell JR; Wood K; Cho MT; van Bokhoven H; Muenke M; Kleefstra T; Bodmer R; de Brouwer APM
Am J Hum Genet; 2020 Jul; 107(1):164-172. PubMed ID: 32553196
[TBL] [Abstract][Full Text] [Related]
19. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].
Pan YX; Wu Y; Niu ZP; Jiang YW
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
